PremiumPre-EarningsOrasure (OSUR) Q4 Earnings Cheat Sheet OraSure’s OraQuick HIV Self-Test now approved for use in adolescents OraSure price target lowered to $4 from $5 at Evercore ISI PremiumThe FlyOraSure reports Q3 EPS (1c), consensus (8c) OraSure sees Q4 revenue $36M-$38M, consensus $37.94M OraSure Technologies Shifts Focus Amid Revenue Drop PremiumCompany AnnouncementsOrasure Technologies Discusses Quarterly Financials and Business Updates OraSure price target lowered to $4.50 from $5.50 at Evercore ISI OraSure supports HIV testing initiatives for National HIV Testing Day